01273 704473

info@novuscomms.com

01273 704473

info@novuscomms.com

#TSP TruSpine Technologies PLC – Subscription, Director/PDMR Dealing & RPT October 15, 2025 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that it has raised gross proceeds of approximately £119,344 through a subscription (the “Subscription”) for 23,869,043 new ordinary shares of 0.01p each in the Company (“Subscription Shares”) at a price of 0.5 pence per share (the “Issue Price”).   Use of Proceeds The net proceeds of the Subscription will be used to provide additional working capital for the Company as…

Continue reading

#TSP TruSpine Technologies PLC – AGM Statement April 10, 2025 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that Geoff Miller, Non-executive Chairman of the Company, will provide the following statement at its annual general meeting to be held today:   “Over the year since I joined the TruSpine Board, we have sought to refocus the Company on delivering value for shareholders. I am pleased to report that considerable progress has been made in this regard.   The…

Continue reading

#HVO hVIVO PLC – £2m hMPV characterisation study contract February 17, 2025 – Posted in: hVIVO (HVO)

hVIVO plc (AIM: HVO), a fast-growing early-stage Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, announces that, following the success of its pilot human metapneumovirus (“hMPV”) characterisation trial announced in January 2025, it has signed a £2 million contract with a new biopharmaceutical client to complete the final stage of the characterisation study ahead of future hMPV human challenge trials (“HCTs”).   The pilot characterisation trial produced a safe, measurable…

Continue reading

#TSP TruSpine Technologies PLC – New Interactive Investor Hub June 7, 2024 – Posted in: TruSpine Plc (TSP), Uncategorized

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, is pleased to announce the launch of its new Interactive Investor Hub. For both existing and prospective shareholders, the new investor hub brings all TruSpine content into a single integrated platform to better inform and engage with investors and stakeholders, including: ●     Regulatory announcements ●     Reports ●     Presentations ●     Educational material ●     Interviews ●     Corporate research   The investor hub also…

Continue reading

#VELA investee co. R8 Capital Investments PLC – Update on Proposed Transaction November 10, 2023 – Posted in: Vela Technologies Plc (VELA)

Further to the announcement on 2 October 2023 regarding the Company entering into heads of terms with Redwood Financial Partners Limited (“RFPL”) in relation to the proposed acquisition by the Company of the entire issued share capital of RFPL (the “Transaction”), the Company would like to provide an update on the likely timeframe for completion.  The parties have agreed to target completion of the Transaction on or around 1 July 2024.  The extended timeframe is…

Continue reading